Parkside Financial Bank & Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.05M | Sell |
72,976
-446
| -0.6% | -$11.9K | 0.16% | 99 |
|
|
2025
Q4 | $1.83M | Buy |
73,422
+3,616
| +5% | +$91.2K | 0.14% | 105 |
|
|
2025
Q3 | $1.78M | Buy |
69,806
+9,037
| +15% | +$223K | 0.14% | 102 |
|
|
2025
Q2 | $1.47M | Buy |
60,769
+14,170
| +30% | +$330K | 0.16% | 109 |
|
|
2025
Q1 | $1.18M | Buy |
46,599
+108
| +0.2% | +$2.83K | 0.15% | 113 |
|
|
2024
Q4 | $1.23M | Buy |
46,491
+471
| +1% | +$12.8K | 0.16% | 103 |
|
|
2024
Q3 | $1.33M | Sell |
46,020
-4,884
| -10% | -$142K | 0.19% | 94 |
|
|
2024
Q2 | $1.42M | Buy |
50,904
+2,749
| +6% | +$75.7K | 0.22% | 77 |
|
|
2024
Q1 | $1.34M | Sell |
48,155
-2,895
| -6% | -$80.3K | 0.21% | 82 |
|
|
2023
Q4 | $1.47M | Buy |
51,050
+9,073
| +22% | +$274K | 0.27% | 71 |
|
|
2023
Q3 | $1.39M | Buy |
41,977
+197
| +0.5% | +$6.97K | 0.32% | 57 |
|
|
2023
Q2 | $1.53M | Buy |
41,780
+1,345
| +3% | +$52.4K | 0.36% | 51 |
|
|
2023
Q1 | $1.65M | Sell |
40,435
-693
| -2% | -$29.9K | 0.44% | 41 |
|
|
2022
Q4 | $2.11M | Buy |
41,128
+3,164
| +8% | +$152K | 0.61% | 32 |
|
|
2022
Q3 | $1.66M | Sell |
37,964
-394
| -1% | -$19.1K | 0.53% | 34 |
|
|
2022
Q2 | $2.01M | Buy |
38,358
+2,866
| +8% | +$146K | 0.61% | 29 |
|
|
2022
Q1 | $1.84M | Sell |
35,492
-2,953
| -8% | -$153K | 0.49% | 35 |
|
|
2021
Q4 | $2.27M | Buy |
38,445
+1,759
| +5% | +$87.2K | 0.56% | 28 |
|
|
2021
Q3 | $1.58M | Sell |
36,686
-700
| -2% | -$31K | 0.46% | 33 |
|
|
2021
Q2 | $1.46M | Buy |
37,386
+353
| +1% | +$13.7K | 0.42% | 36 |
|
|
2021
Q1 | $1.34M | Sell |
37,033
-1,123
| -3% | -$39.9K | 0.41% | 40 |
|
|
2020
Q4 | $1.4M | Buy |
38,156
+3,273
| +9% | +$120K | 0.44% | 37 |
|
|
2020
Q3 | $1.21M | Sell |
34,883
-5,714
| -14% | -$200K | 0.42% | 38 |
|
|
2020
Q2 | $1.26M | Buy |
40,597
+1,293
| +3% | +$43.9K | 0.41% | 40 |
|
|
2020
Q1 | $1.22M | Sell |
39,304
-2,066
| -5% | -$70.4K | 0.46% | 34 |
|
|
2019
Q4 | $1.54M | Buy |
41,370
+1,071
| +3% | +$38.1K | 0.45% | 36 |
|
|
2019
Q3 | $1.37M | Buy |
40,299
+509
| +1% | +$18.5K | 0.44% | 38 |
|
|
2019
Q2 | $1.64M | Buy |
39,790
+468
| +1% | +$18.6K | 0.53% | 28 |
|
|
2019
Q1 | $1.58M | Buy |
39,322
+530
| +1% | +$21.2K | 0.53% | 28 |
|
|
2018
Q4 | $1.61M | Buy |
38,792
+86
| +0.2% | +$3.57K | 0.57% | 28 |
|
|
2018
Q3 | $1.62M | Sell |
38,706
-1,251
| -3% | -$48.2K | 0.56% | 24 |
|
|
2018
Q2 | $1.38M | Sell |
39,957
-1,962
| -5% | -$67K | 0.51% | 32 |
|
|
2018
Q1 | $1.41M | Sell |
41,919
-235
| -0.6% | -$8.08K | 0.54% | 29 |
|
|
2017
Q4 | $1.45M | Buy |
42,154
+896
| +2% | +$30.6K | 0.53% | 30 |
|
|
2017
Q3 | $1.4M | Buy |
41,258
+2,276
| +6% | +$73.2K | 0.55% | 29 |
|
|
2017
Q2 | $1.24M | Buy |
38,982
+649
| +2% | +$20.5K | 0.51% | 32 |
|
|
2017
Q1 | $1.24M | Sell |
38,333
-94
| -0.2% | -$2.96K | 0.54% | 33 |
|
|
2016
Q4 | $1.19M | Buy |
38,427
+6,069
| +19% | +$185K | 0.52% | 36 |
|
|
2016
Q3 | $1.04M | Buy |
32,358
+398
| +1% | +$13.3K | 0.48% | 44 |
|
|
2016
Q2 | $1.07M | Sell |
31,960
-2,081
| -6% | -$66.4K | 0.52% | 39 |
|
|
2016
Q1 | $957K | Buy |
34,041
+1,213
| +4% | +$34.6K | 0.48% | 40 |
|
|
2015
Q4 | $1M | Sell |
32,828
-724
| -2% | -$22.8K | 0.5% | 35 |
|
|
2015
Q3 | $1M | Sell |
33,552
-15,058
| -31% | -$483K | 0.57% | 30 |
|
|
2015
Q2 | $1.55M | Sell |
48,610
-718
| -1% | -$23.4K | 0.82% | 30 |
|
|
2015
Q1 | $1.63M | Buy |
49,328
+5,273
| +12% | +$168K | 0.87% | 26 |
|
|
2014
Q4 | $1.3M | Sell |
44,055
-2,157
| -5% | -$61.8K | 0.73% | 37 |
|
|
2014
Q3 | $1.3M | Sell |
46,212
-2,473
| -5% | -$69.4K | 0.79% | 35 |
|
|
2014
Q2 | $1.37M | Buy |
48,685
+2,372
| +5% | +$67.6K | 0.82% | 31 |
|
|
2014
Q1 | $1.41M | Sell |
46,313
-1,173
| -2% | -$35K | 0.88% | 31 |
|
|
2013
Q4 | $1.38M | Buy |
47,486
+1,216
| +3% | +$35.4K | 0.94% | 30 |
|
|
2013
Q3 | $1.26M | Buy |
46,270
+488
| +1% | +$13.3K | 0.98% | 30 |
|
|
2013
Q2 | $1.22M | Buy |
+45,782
| New | +$1.26M | 0.96% | 30 |
|
Other funds holding PFE
Parkside Financial Bank & Trust's PFE Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Pfizer (PFE) stake by 0.61% in Q1 2026, selling an estimated $11.9K and leaving 72,976 shares worth $2.05M. The position accounts for 0.16% of the portfolio, ranked #99.
Parkside Financial Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.27M in Q4 2021. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Parkside Financial Bank & Trust held 72,976 shares of Pfizer worth $2.05M as of Q1 2026.
- Parkside Financial Bank & Trust sold 446 Pfizer shares in Q1 2026, an estimated $11.9K.
- Pfizer made up 0.16% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #99 holding.
- Parkside Financial Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Parkside Financial Bank & Trust's Pfizer position peaked at $2.27M in Q4 2021.
- 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.